Zacks Investment Research on MSN
Here is what to know beyond why Bristol Myers Squibb Company (BMY) is a trending stock
Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best High Yield Stocks to Buy. On January 7, UBS upgraded ...
Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive ...
Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at ...
5d
Bristol-Myers Squibb (BMY) Upgraded to Buy by UBS, Noting a Skewed Risk/Reward Ratio for the Stock
The firm highlighted that Bristol-Myers Squibb Company (NYSE:BMY) will face loss of exclusivity challenges up to 2028, ...
If you are wondering whether Bristol-Myers Squibb is offering good value at around US$54.94 per share, you are not alone. Many investors are asking the same question right now. The stock has had mixed ...
Zacks.com on MSN
Is BMY's Deep Pipeline the Key to Its Next Growth Phase?
Bristol Myers Squibb BMY highlighted the potential of its deep and promising pipeline at the 44th Annual J.P. Morgan ...
Bristol Myers Squibb remains significantly undervalued, trading at a forward P/E of 8x, versus the sector median of 19.5x. BMY's growth portfolio now generates 57% of total revenue, growing 18% YoY ...
Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
Bristol Myers Squibb Company BMY has delivered a solid performance in recent months. The biotech major’s shares have gained 17.3% over the past six months compared with the industry ’s growth of 23.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results